[DOI] [PMC free article] [PubMed] [Google Scholar] 43.He W., Hu S., Du X., Wen Q., Zhong X.-P., Zhou X., Zhou C., Xiong W., Gao Y., Zhang S
When treated with both the 1.44 mg/kg dose and the 2.88 mg/kg dose of Dihexa, the APP/PS1 mice experienced an increase in the number of neuronal cells present in the cerebral cortex
This activation occurs through a mechanism distinct from SSRIs, potentially explaining why TREK-1 channel blockers may help people who do not respond to conventional serotonin-based treatments
work on an alcohol-wiped surface
Healthy participants with no personal or family history of psychotic disorders were recruited from the local community via posters, and matched group-wise to the patient group for age, gender, and parental socio-economic status (SA3)